{"id":"W6949684207","doi":"10.5281/zenodo.16575676","title":"Perspectives and Insights on Antineoplastic Agents with Diverse Mechanisms of Action (L01XX): From Development to New Drug Application (NDA) Submission for FDA","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Drug; Action (physics); Drug approval; Drug delivery; Antineoplastic Drugs; Cancer drugs; Cancer; Site of action","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009104273,0.0001119514,0.0001474153,0.000217524,0.0004946841,0.00005414375,0.00014395,0.0000314932,0.0003958932],"category_scores_gemma":[0.0001328852,0.00009841292,0.0000174431,0.0003149518,0.00004579188,0.0000962116,0.0001706042,0.00008719621,0.0001065029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001789633,"about_ca_system_score_gemma":0.00001765272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002158789,"about_ca_topic_score_gemma":0.000001474299,"domain_scores_codex":[0.9991023,0.00004043062,0.0001432279,0.0003433684,0.0002330962,0.0001376105],"domain_scores_gemma":[0.9992217,0.00002850252,0.00007805528,0.0001979694,0.000346986,0.0001268013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006394697,0.0004614448,0.00003455184,0.000305149,0.0002959018,0.000005384564,0.02464036,0.0001977114,0.2163691,0.007009683,0.01008511,0.7342009],"study_design_scores_gemma":[0.005268147,0.001095221,0.01612553,0.0006536045,0.00011006,0.00002104313,0.009996867,0.0005834068,0.1333085,0.002065024,0.8304667,0.0003058665],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5227701,0.00009495449,0.471504,0.001277503,0.00006243419,0.001549094,0.00006355871,0.0002762628,0.002402078],"genre_scores_gemma":[0.9899836,0.00002315429,0.008232778,0.0001267998,0.00003908857,3.646585e-7,0.0003455939,0.0002534155,0.000995175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8203816,"threshold_uncertainty_score":0.4334753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02759747095780769,"score_gpt":0.2807595226296699,"score_spread":0.2531620516718622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}